Analysts See $-0.07 EPS for Cryoport, Inc. (CYRX)

July 14, 2018 - By Nadine Davis

Analysts expect Cryoport, Inc. (NASDAQ:CYRX) to report $-0.07 EPS on August, 14.They anticipate $0.01 EPS change or 12.50 % from last quarter’s $-0.08 EPS. After having $-0.10 EPS previously, Cryoport, Inc.’s analysts see -30.00 % EPS growth. The stock decreased 0.06% or $0.01 during the last trading session, reaching $15.64. About 182,083 shares traded. Cryoport, Inc. (NASDAQ:CYRX) has risen 259.88% since July 14, 2017 and is uptrending. It has outperformed by 247.31% the S&P500.

CryoPort, Inc. provides cryogenic logistics solutions to the life sciences industry in the United States, Europe, Asia, and internationally. The company has market cap of $432.91 million. The firm offers Cryoportal, a cloud logistics management software that automates the entry of orders, prepares customs documentation, and facilitates status and location monitoring of shipped orders while in transit; and CryoPort Express Shippers, which are cryogenic dry vapor shippers that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures. It currently has negative earnings. It also provides Cryoport Express Standard Shippers, which are re-usable dry vapor liquid nitrogen storage containers for holding the biological material in the inner chamber; CryoPort Express High Volume Shippers, which use a dry vapor liquid nitrogen technology to maintain temperatures; and Cryoport Express CXVC1 Shipper, which is in dry vapor form and based on the standard dry shipper technology, and utilizes an absorbent material to hold LN2.

More news for Cryoport, Inc. (NASDAQ:CYRX) were recently published by:, which released: “Midday Stock Roundup” on July 03, 2018.‘s article titled: “CryoPort (CYRX) PT Raised to $19 at Needham & Company” and published on July 02, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.